Synthetic cathinone pharmacokinetics, analytical methods, and toxicological findings from human performance and postmortem cases

References

• Adamowicz P, Gil D, Skulska A, Tokarczyk B. (2013a). Analysis of MDPV in blood – determination and interpretation. J Anal Toxicol 37:308–312.
   PubMed Web of Science ®Google Scholar
• Adamowicz P, Tokarczyk B. (2015). Simple and rapid screening procedure for 143 new psychoactive substances by liquid chromatography-tandem mass spectrometry. Drug Test Anal. [Epub ahead of print]. doi: 10.1002/dta.1815.
   Web of Science ®Google Scholar
• Adamowicz P, Tokarczyk B, Stanaszek R, Slopianka M. (2013b). Fatal mephedrone intoxication – a case report. J Anal Toxicol 37:37–42.
   PubMed Web of Science ®Google Scholar
• Al-Saffar Y, Stephanson NN, Beck O. (2013). Multicomponent LC-MS/MS screening method for detection of new psychoactive drugs, legal highs, in urine-experience from the Swedish population. J Chromatogr B Analyt Technol Biomed Life Sci 930:112–120.
   PubMed Web of Science ®Google Scholar
• Amaratunga P, Lorenz Lemberg B, Lemberg D. (2013). Quantitative measurement of synthetic cathinones in oral fluid. J Anal Toxicol 37:622–628.
   PubMed Web of Science ®Google Scholar
• Ambach L, Hernandez Redondo A, Konig S, Weinmann W. (2014). Rapid and simple LC-MS/MS screening of 64 novel psychoactive substances using dried blood spots. Drug Test Anal 6:367–375.
   PubMed Web of Science ®Google Scholar
• Anizan S, Concheiro M, Lehner KR, et al. (2016). Linear pharmacokinetics of 3,4-methylenedioxypyrovalerone (MDPV) and its metabolites in the rat: relationship to pharmacodynamic effects. Addict Biol 21:339–347.
   PubMed Web of Science ®Google Scholar
• Anizan S, Ellefsen K, Concheiro M, et al. (2014). 3,4-Methylenedioxypyrovalerone (MDPV) and metabolites quantification in human and rat plasma by liquid chromatography–high resolution mass spectrometry. Anal Chim Acta 827:54–63.
   PubMed Web of Science ®Google Scholar
• Archer RP. (2009). Fluoromethcathinone, a new substance of abuse. Forensic Sci Int 185:10–20.
   PubMed Web of Science ®Google Scholar
• Balikova M, Zidkova M, Oktabec Z, et al. (2013). The abuse of 3,4-methylenedioxypyrrolidinobutiophenone (MDPBP): A case report. J Forensic Toxiciol Pharmacol 2:1–4.
   Google Scholar
• Baumann MH, Ayestas MA, Jr., Partilla JS, et al. (2012). The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology 37:1192–1203.
   PubMed Web of Science ®Google Scholar
• Baumann MH, Partilla JS, Lehner KR. (2013a). Psychoactive “ ‘bath salts’: not so soothing”. Eur J Pharmacol 698:1–5.
   PubMed Web of Science ®Google Scholar
• Baumann MH, Partilla JS, Lehner KR, et al. (2013b). Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive ‘bath salts’ products. Neuropsychopharmacology 38:552–562.
   PubMed Web of Science ®Google Scholar
• Bertol E, Mari F, Boscolo Berto R, et al. (2014). A mixed MDPV and benzodiazepine intoxication in a chronic drug abuser: Determination of MDPV metabolites by LC-HRMS and discussion of the case. Forensic Sci Int 243:149–155.
   PubMed Web of Science ®Google Scholar
• Borek HA, Holstege CP. (2012). Hyperthermia and multiorgan failure after abuse of “ ‘bath salts’ containing 3,4-methylenedioxypyrovalerone”. Ann Emerg Med 60:103–105.
   PubMed Web of Science ®Google Scholar
• Busardo FP, Kyriakou C, Tittarelli R, et al. (2015). Assessment of the stability of mephedrone in ante-mortem and post-mortem blood specimens. Forensic Sci Int 256:28–37.
   PubMed Web of Science ®Google Scholar
• Carbone PN, Carbone DL, Carstairs SD, Luzi SA. (2013). Sudden cardiac death associated with methylone use. Am J Forensic Med Pathol 34:26–28.
   PubMed Web of Science ®Google Scholar
• Cawrse BM, Levine B, Jufer RA, et al. (2012). Distribution of methylone in four postmortem cases. J Anal Toxicol 36:434–439.
   PubMed Web of Science ®Google Scholar
• Concheiro M, Anizan S, Ellefsen K, Huestis MA. (2013). Simultaneous quantification of 28 synthetic cathinones and metabolites in urine by liquid chromatography-high resolution mass spectrometry. Anal Bioanal Chem 405:9437–9448.
   PubMed Web of Science ®Google Scholar
• Concheiro M, Castaneto M, Kronstrand R, Huestis MA. (2015). Simultaneous determination of 40 novel psychoactive stimulants in urine by liquid chromatography–high resolution mass spectrometry and library matching. J Chromatogr A 1397:32–42.
   PubMed Web of Science ®Google Scholar
• Coppola M, Mondola R. (2012). 3,4-Methylenedioxypyrovalerone (MDPV): Chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online. Toxicol Lett 208:12–15.
   PubMed Web of Science ®Google Scholar
• Cosbey SH, Peters KL, Quinn A, Bentley A. (2013). Mephedrone (methylmethcathinone) in toxicology casework: A Northern Ireland perspective. J Anal Toxicol 37:74–82.
   PubMed Web of Science ®Google Scholar
• Dargan PI, Sedefov R, Gallegos A, Wood DM. (2011). The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone). Drug Test Anal 3:454–463.
   PubMed Web of Science ®Google Scholar
• De Castro A, Lendoiro E, Fernandez-Vega H, et al. (2014). Liquid chromatography tandem mass spectrometry determination of selected synthetic cathinones and two piperazines in oral fluid. Cross reactivity study with an on-site immunoassay device. J Chromatogr A 1374:93–101.
   PubMed Web of Science ®Google Scholar
• Derungs A, Schietzel S, Meyer MR, et al. (2011). Sympathomimetic toxicity in a case of analytically confirmed recreational use of naphyrone (naphthylpyrovalerone). Clin Toxicol (Phila) 49:691–693.
   PubMed Web of Science ®Google Scholar
• Dickson AJ, Vorce SP, Levine B, Past MR. (2010). Multiple-drug toxicity caused by the coadministration of 4-methylmethcathinone (mephedrone) and heroin. J Anal Toxicol 34:162–168.
   PubMed Web of Science ®Google Scholar
• Dragogna F, Oldani L, Buoli M, Altamura AC. (2014). A case of severe psychosis induced by novel recreational drugs. F1000Res 3:21.
   PubMedGoogle Scholar
• Ellefsen KN, Anizan S, Castaneto MS, et al. (2014). Validation of the only commercially available immunoassay for synthetic cathinones in urine: Randox drugs of abuse V biochip array technology. Drug Test Anal 6:728–738.
   PubMed Web of Science ®Google Scholar
• Ellefsen K, Concheiro M, Suzuki M, et al. (2015). Quantification of methylone and metabolites in rat and human plasma by liquid chromatography-tandem mass spectrometry. Forensic Toxicol 33:202–212.
   Web of Science ®Google Scholar
• Ellefsen K, Wohlfarth A, Swortwood M, et al. (2016). 4-Methoxy-α-PVP: In silico prediction, metabolic stability, and metabolite identification by human hepatocyte incubation and high-resolution mass spectrometry. Forensic Toxicol 34:61–75.
   PubMed Web of Science ®Google Scholar
• Eshleman AJ, Wolfrum KM, Hatfield MG, et al. (2013). Substituted methcathinones differ in transporter and receptor interactions. Biochem Pharmacol 85:1803–1815.
   PubMed Web of Science ®Google Scholar
• European Centre for Drugs and Drug Addiction (EMCDDA). (2011). Risk assessment report of a new pyschoactive substance- 4-methylmethcathinone (mephedrone). Lisbon, Portugal.
   Google Scholar
• European Centre for Drugs and Drug Addiction (EMCDDA). (2015a). New psychoactive substances in Europe – An update from the EU Early Warning System. doi:10.2810/372415.
   Google Scholar
• European Centre for Drugs and Drug Addiction (EMCDDA). (2015b). Perspective on Drugs: Injection of Synthetic Cathinones [Online]. Available: http://www.emcdda.europa.eu/topics/pods/synthetic-cathinones-injection#panel1 [last accessed 23 Feb 2016].
   Google Scholar
• Froberg BA, Levine M, Beuhler MC, et al. (2015). Acute methylenedioxypyrovalerone toxicity. J Med Toxicol 11:185–194.
   PubMed Web of Science ®Google Scholar
• Gil D, Adamowicz P, Skulska A, et al. (2013). Analysis of 4-MEC in biological and non-biological material – Three case reports. Forensic Sci Int 228:e11–e15.
   PubMed Web of Science ®Google Scholar
• Hagan KS, Reidy L. (2015). Detection of synthetic cathinones in victims of sexual assault. Forensic Sci Int 257:71–75.
   PubMed Web of Science ®Google Scholar
• Hasegawa K, Suzuki O, Wurita A, et al. (2014a). Postmortem distribution of α-pyrrolidinovalerophenone and its metabolite in body fluids and solid tissues in a fatal poisoning case measured by LC–MS–MS with the standard addition method. Forensic Toxicol 32:225–234.
   Web of Science ®Google Scholar
• Hasegawa K, Wurita A, Minakata K, et al. (2014b). Identification and quantitation of a new cathinone designer drug PV9 in an ‘‘aroma liquid’’ product, antemortem whole blood and urine specimens, and a postmortem whole blood specimen in a fatal poisoning case. Forensic Toxicol 32:243–250.
   Web of Science ®Google Scholar
• Helfer AG, Turcant A, Boels D, et al. (2015). Elucidation of the metabolites of the novel psychoactive substance 4-methyl-N-ethyl-cathinone (4-MEC) in human urine and pooled liver microsomes by GC-MS and LC-HR-MS/MS techniques and of its detectability by GC-MS or LC-MS(n) standard screening approaches. Drug Test Anal 7:368–375.
   PubMed Web of Science ®Google Scholar
• Hill SL, Thomas SH. (2011). Clinical toxicology of newer recreational drugs. Clin Toxicol (Phila) 49:705–719.
   PubMed Web of Science ®Google Scholar
• Iversen L, Gibbons S, Treble R, et al. (2013). Neurochemical profiles of some novel psychoactive substances. Eur J Pharmacol 700:147–151.
   PubMed Web of Science ®Google Scholar
• James D, Adams RD, Spears R, et al. (2011). Clinical characteristics of mephedrone toxicity reported to the U.K. National Poisons Information Service. Emerg Med J 28:686–689.
   PubMed Web of Science ®Google Scholar
• John ME, Thomas-Rozea C, Hahn D. (2014). Bath salts abuse leading to new onset psychosis and potential for violence. Clin Schizophr Relat Psychoses. [Epub ahead of print]. doi: 10.3371/CSRP.JORO.061314.
   PubMedGoogle Scholar
• Johnson RD, Botch-Jones SR. (2013). The stability of four designer drugs: MDPV, mephedrone, BZP and TFMPP in three biological matrices under various storage conditions. J Anal Toxicol 37:51–55.
   PubMed Web of Science ®Google Scholar
• Kaizaki A, Tanaka S, Numazawa S. (2014). New recreational drug 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone (alpha-PVP) activates central nervous system via dopaminergic neuron. J Toxicol Sci 39:1–6.
   PubMed Web of Science ®Google Scholar
• Kamata HT, Shima N, Zaitsu K, et al. (2006). Metabolism of the recently encountered designer drug, methylone, in humans and rats. Xenobiotica 36:709–723.
   PubMed Web of Science ®Google Scholar
• Kasick DP, Mcknight CA, Klisovic E. (2012). “ ‘Bath salt’ ingestion leading to severe intoxication delirium: Two cases and a brief review of the emergence of mephedrone use”. Am J Drug Alcohol Abuse 38:176–180.
   PubMed Web of Science ®Google Scholar
• Katagi M. (2010). Metabolism and forensic toxicological analyses of the extensively abused designer drug methylone. TIAFT Bull 40:30–35.
   Google Scholar
• Kerrigan S, Savage M, Cavazos C, Bella P. (2016). Thermal degradation of synthetic cathinones: implications for forensic toxicology. J Anal Toxicol 40:1–11.
   PubMed Web of Science ®Google Scholar
• Kesha K, Boggs CL, Ripple MG, et al. (2013). Methylenedioxypyrovalerone (“(‘bath salts’), related death: Case report and review of the literature”). J Forensic Sci 58:1654–1659.
   PubMed Web of Science ®Google Scholar
• Khreit OI, Grant MH, Zhang T, et al. (2013). Elucidation of the Phase I and Phase II metabolic pathways of (+/-)-4’-methylmethcathinone (4-MMC) and (+/−)-4’-(trifluoromethyl)methcathinone (4-TFMMC) in rat liver hepatocytes using LC-MS and LC-MS(2). J Pharm Biomed Anal 72:177–185.
   PubMed Web of Science ®Google Scholar
• Khullar V, Jain A, Sattari M. (2014). Emergence of new classes of recreational drugs-synthetic cannabinoids and cathinones. J Gen Intern Med 29:1200–1204.
   PubMed Web of Science ®Google Scholar
• Knoy JL, Peterson BL, Couper FJ. (2014). Suspected impaired driving case involving α-pyrrolidinovalerophenone, methylone and ethylone. J Anal Toxicol 38:615–617.
   PubMed Web of Science ®Google Scholar
• Kovacs K, Toth AR, Kereszty EM. (2012). A new designer drug: methylone related death. Orv Hetil 153:271–276.
   PubMedGoogle Scholar
• Kriikku P, Wilhelm L, Schwarz O, Rintatalo J. (2011). New designer drug of abuse: 3,4-Methylenedioxypyrovalerone (MDPV). Findings from apprehended drivers in Finland. Forensic Sci Int 210:195–200.
   PubMed Web of Science ®Google Scholar
• Lee D, Chronister CW, Hoyer J, Goldberger BA. (2015). Ethylone-related deaths: Toxicological findings. J Anal Toxicol 39:567–571.
   PubMed Web of Science ®Google Scholar
• Liechti M. (2015). Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling. Swiss Med Wkly 145:w14043.
   PubMed Web of Science ®Google Scholar
• Loi B, Corkery JM, Claridge H, et al. (2015). Deaths of individuals aged 16–24 years in the UK after using mephedrone. Hum Psychopharmacol 30:225–232.
   PubMed Web of Science ®Google Scholar
• Lopez-Arnau R, Martinez-Clemente J, Pubill D, et al. (2012). Comparative neuropharmacology of three psychostimulant cathinone derivatives: Butylone, mephedrone and methylone. Br J Pharmacol 167:407–420.
   PubMed Web of Science ®Google Scholar
• Lopez-Arnau R, Martinez-Clemente J, Carbo M, et al. (2013). An integrated pharmacokinetic and pharmacodynamic study of a new drug of abuse, methylone, a synthetic cathinone sold as “bath salts”. Prog Neuropsychopharmacol Biol Psychiatry 45:64–72.
   PubMed Web of Science ®Google Scholar
• Lusthof KJ, Oosting R, Maes A, et al. (2011). A case of extreme agitation and death after the use of mephedrone in The Netherlands. Forensic Sci Int 206:e93–e95.
   PubMed Web of Science ®Google Scholar
• Maas A, Wippich C, Madea B, Hess C. (2015). Driving under the influence of synthetic phenethylamines: A case series. Int J Legal Med 129:997–1003.
   PubMed Web of Science ®Google Scholar
• Macher AM, Penders TM. (2013). False-positive phencyclidine immunoassay results caused by 3,4-methylenedioxypyrovalerone (MDPV). Drug Test Anal 5:130–132.
   PubMed Web of Science ®Google Scholar
• Mangold AR, Bravo TP, Traub SJ, et al. (2014). Flashback phenomenon and residual neurological deficits after the use of “ ‘bath salt‘ 3, 4-methylenedioxypyrovalerone”. World J Emerg Med 5:63–66.
   PubMedGoogle Scholar
• Marinetti LJ, Antonides HM. (2013). Analysis of synthetic cathinones commonly found in bath salts in human performance and postmortem toxicology: Method development, drug distribution and interpretation of results. J Anal Toxicol 37:135–146.
   PubMed Web of Science ®Google Scholar
• Martinez-Clemente J, Lopez-Arnau R, Carbo M, et al. (2013). Mephedrone pharmacokinetics after intravenous and oral administration in rats: Relation to pharmacodynamics. Psychopharmacology (Berl) 229:295–306.
   PubMed Web of Science ®Google Scholar
• Marusich JA, Antonazzo KR, Wiley JL, et al. (2014). Pharmacology of novel synthetic stimulants structurally related to the “bath salts” constituent 3,4-methylenedioxypyrovalerone (MDPV). Neuropharmacology 87:206–213.
   PubMed Web of Science ®Google Scholar
• Maskell PD, De Paoli G, Seneviratne C, Pounder DJ. (2011). Mephedrone (4-methylmethcathinone)-related deaths. J Anal Toxicol 35:188–191.
   PubMed Web of Science ®Google Scholar
• McIntyre IM, Hamm CE, Aldridge L, Nelson CL. (2013). Acute methylone intoxication in an accidental drowning – A case report. Forensic Sci Int 231:e1–e3.
   PubMed Web of Science ®Google Scholar
• McIntyre IM, Hamm CE, Sherrard JL, et al. (2015). Acute 3,4-methylenedioxy-N-ethylcathinone (ethylone) intoxication and related fatality: A case report with postmortem concentrations. J Anal Toxicol 39:225–228.
   PubMed Web of Science ®Google Scholar
• Meyer MR, Du P, Schuster F, Maurer HH. (2010a). Studies on the metabolism of the α-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC–MS and LC–high-resolution MS and its detectability in urine by GC–MS. J Mass Spectrom 45:1426–1442.
   PubMed Web of Science ®Google Scholar
• Meyer MR, Wilhelm J, Peters FT, Maurer HH. (2010b). Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry. Anal Bioanal Chem 397:1225–1233.
   PubMed Web of Science ®Google Scholar
• Meyer MR, Vollmar C, Schwaninger AE, et al. (2012). New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: Studies on their metabolism in rat urine and human liver microsomes using GC–MS and LC–high-resolution MS and their detectability in urine. J Mass Spectrom 47:253–262.
   PubMed Web of Science ®Google Scholar
• Meyer MR, Prosser D, Maurer HH. (2013). Studies on the metabolism and detectability of the designer drug β-naphyrone in rat urine using GC-MS and LC-HR-MS/MS. Drug Test Anal 5:259–265.
   PubMed Web of Science ®Google Scholar
• Meyer MR, Mauer S, Meyer GMJ, et al. (2014). The in vivo and in vitro metabolism and the detectability in urine of 3′,4′-methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP), a new pyrrolidinophenone-type designer drug, studied by GC-MS and LC-MSn. Drug Test Anal 6:746–756.
   PubMed Web of Science ®Google Scholar
• Minakata K, Yamagishi I, Nozawa H, et al. (2015). Determination of new pyrrolidino cathinone derivatives, PVT, F-PVP, MPHP, PV8, PV9 and F-PV9, in human blood by MALDI-Q-TOF mass spectrometry. Forensic Toxicol 33:148–154.
   Web of Science ®Google Scholar
• Mueller DM, Rentsch KM. (2012). Generation of metabolites by an automated online metabolism method using human liver microsomes with subsequent identification by LC-MS(n), and metabolism of 11 cathinones. Anal Bioanal Chem 402:2141–2151.
   PubMed Web of Science ®Google Scholar
• Murray BL, Murphy CM, Beuhler MC. (2012). Death following recreational use of designer drug “bath salts” containing 3,4-methylenedioxypyrovalerone (MDPV). J Med Toxicol 8:69–75.
   PubMedGoogle Scholar
• Namera A, Konuma K, Kawamura M, et al. (2014). Time-course profile of urinary excretion of intravenously administered α-pyrrolidinovalerophenone and α-pyrrolidinobutiophenone in a human. Forensic Toxicol 32:68–74.
   Web of Science ®Google Scholar
• National Conference of State Legislatures (NCSL). (2015). Synthetic Drug Threats. [Online]. Available: http://www.ncsl.org/research/civil-and-criminal-justice/synthetic-drug-threats.aspx [last accessed 14 Sep 2015].
   Google Scholar
• Negreira N, Erratico C, Kosjek T, et al. (2015). In vitro Phase I and Phase II metabolism of alpha-pyrrolidinovalerophenone (alpha-PVP), methylenedioxypyrovalerone (MDPV) and methedrone by human liver microsomes and human liver cytosol. Anal Bioanal Chem 407:5803–5816.
   PubMed Web of Science ®Google Scholar
• Odoardi S, Fisichella M, Romolo FS, Strano-Rossi S. (2015). High-throughput screening for new psychoactive substances (NPS) in whole blood by DLLME extraction and UHPLC-MS/MS analysis. J Chromatogr B: Anal Technol Biomed Life Sci 1000:57–68.
   PubMed Web of Science ®Google Scholar
• Palamar JJ, Martins SS, Su MK, Ompad DC. (2015). Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting. Drug Alcohol Depend 156:112–119.
   PubMed Web of Science ®Google Scholar
• Pasin D, Bidny S, Fu S. (2015). Analysis of new designer drugs in post-mortem blood using high-resolution mass spectrometry. J Anal Toxicol 39:163–171.
   PubMed Web of Science ®Google Scholar
• Paul M, Ippisch J, Herrmann C, et al. (2014). Analysis of new designer drugs and common drugs of abuse in urine by a combined targeted and untargeted LC-HR-QTOFMS approach. Anal Bioanal Chem 406:4425–4441.
   PubMed Web of Science ®Google Scholar
• Pawlik E, Plasser G, Mahler H, Daldrup T. (2012). Studies on the phase I metabolism of the new designer drug 3-fluoromethcathinone using rabbit liver slices. Int J Legal Med 126:231–240.
   PubMed Web of Science ®Google Scholar
• Pearson JM, Hargraves TL, Hair LS, et al. (2012). Three fatal intoxications due to methylone. J Anal Toxicol 36:444–451.
   PubMed Web of Science ®Google Scholar
• Pedersen AJ, Petersen TH, Linnet K. (2013a). In vitro metabolism and pharmacokinetic studies on methylone. Drug Metab Dispos 41:1247–1255.
   PubMed Web of Science ®Google Scholar
• Pedersen AJ, Reitzel LA, Johansen SS, Linnet K. (2013b). In vitro metabolism studies on mephedrone and analysis of forensic cases. Drug Test Anal 5:430–438.
   PubMed Web of Science ®Google Scholar
• Penders TM, Gestring RE, Vilensky DA. (2012). Intoxication delirium following use of synthetic cathinone derivatives. Am J Drug Alcohol Abuse 38:616–617.
   PubMed Web of Science ®Google Scholar
• Peters FT, Meyer MR, Fritschi G, Maurer HH. (2005). Studies on the metabolism and toxicological detection of the new designer drug 4’-methyl-alpha-pyrrolidinobutyrophenone (MPBP) in rat urine using gas chromatography-mass spectrometry. J Chromatogr B: Anal Technol Biomed Life Sci 824:81–91.
   PubMed Web of Science ®Google Scholar
• Pichini S, Rotolo MC, Garcia J, et al. (2014). Neonatal withdrawal syndrome after chronic maternal consumption of 4-methylethcathinone. Forensic Sci Int 245C:e33–e35.
   Web of Science ®Google Scholar
• Pinorini-Godly MT, Sporket F, Schlapfer M, et al. (2010). Intoxication with butylone and phenazepam among young cocaine users. Toxichem. Krimtech 77:226–227.
   Google Scholar
• Pozo OJ, Ibanez M, Sancho JV, et al. (2015). Mass spectrometric evaluation of mephedrone in vivo human metabolism: identification of phase I and phase II metabolites, including a novel succinyl conjugate. Drug Metab Dispos 43:248–257.
   PubMed Web of Science ®Google Scholar
• Regester LE, Chmiel JD, Holler JM, et al. (2015). Determination of designer drug cross-reactivity on five commercial immunoassay screening kits. J Anal Toxicol 39:144–151.
   PubMed Web of Science ®Google Scholar
• Rojek S, Klys M, Strona M, et al. (2012). ‘Legal highs‘-toxicity in the clinical and medico-legal aspect as exemplified by suicide with bk-MBDB administration. Forensic Sci Int 222:e1–e6.
   PubMed Web of Science ®Google Scholar
• Saha K, Partilla JS, Lehner KR, et al. (2015). ‘Second-generation’ mephedrone analogs, 4-MEC and 4-MePPP, differentially affect monoamine transporter function. Neuropsychopharmacology 40:1321–1331.
   PubMed Web of Science ®Google Scholar
• Saito T, Namera A, Osawa M, et al. (2013). SPME–GC–MS analysis of α-pyrrolidinovaleorophenone in blood in a fatal poisoning case. Forensic Toxicol 31:328–332.
   Web of Science ®Google Scholar
• Sauer C, Peters FT, Haas C, et al. (2009). New designer drug alpha-pyrrolidinovalerophenone (PVP): Studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques. J Mass Spectrom 44:952–964.
   PubMed Web of Science ®Google Scholar
• Sauer C, Hoffmann K, Schimmel U, Peters FT. (2011). Acute poisoning involving the pyrrolidinophenone-type designer drug 4'-methyl-alpha-pyrrolidinohexanophenone (MPHP) Forensic Sci Int 208:e20–e25.
   PubMed Web of Science ®Google Scholar
• Schifano F, Albanese A, Fergus S, et al. (2011). Mephedrone (4-methylmethcathinone; 'meow meow'): Chemical, pharmacological and clinical issues. Psychopharmacology (Berl.) 214:593–602.
   PubMed Web of Science ®Google Scholar
• Shima N, Kakehashi H, Matsura S, et al. (2015). Urinary excretion and metabolism of the a-pyrrolidinophenone designer drug 1-phenyl-2-(pyrrolidin-1-yl)octan-1-one (PV9) in humans. Forensic Toxicol 33:279–294.
   Web of Science ®Google Scholar
• Shima N, Katagi M, Kamata H, et al. (2013). Urinary excretion and metabolism of the newly encountered designer drug 3,4-dimethylmethcathinone in humans. Forensic Toxicol 31:101–112.
   Web of Science ®Google Scholar
• Shima N, Katagi M, Kamata H, et al. (2014). Metabolism of the newly encountered designer drug α-pyrrolidinovalerophenone in humans: Identification and quantitation of urinary metabolites. Forensic Toxicol 32:59–67.
   Web of Science ®Google Scholar
• Shintani-Ishida K. (2015). Identification and quantification of 4′-methoxy-α-pyrrolidinobutiophenone (4-MeOPBP) in human plasma and urine using LC–TOF-MS in an autopsy case. Forensic Toxicol 33:348–354.
   Web of Science ®Google Scholar
• Simmler LD, Buser TA, Donzelli M, et al. (2013). Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol 168:458–470.
   PubMed Web of Science ®Google Scholar
• Simmler LD, Rickli A, Hoener MC, Liechti ME. (2014). Monoamine transporter and receptor interaction profiles of a new series of designer cathinones. Neuropharmacology 79:152–160.
   PubMed Web of Science ®Google Scholar
• Soh YNA, Elliott S. (2013). An investigation of the stability of emerging new psychoactive substances. Drug Test Anal 6:696–704.
   PubMed Web of Science ®Google Scholar
• Sorensen LK. (2011). Determination of cathinones and related ephedrines in forensic whole-blood samples by liquid-chromatography-electrospray tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 879:727–736.
   PubMed Web of Science ®Google Scholar
• Spiller HA, Ryan ML, Weston RG, Jansen J. (2011). Clinical experience with and analytical confirmation of “‘bath salts‘ and ‘legal highs‘ (synthetic cathinones) in the United States”. Clin Toxicol (Phila) 49:499–505.
   PubMed Web of Science ®Google Scholar
• Springer D, Fritschi G, Maurer HH. (2003a). Metabolism and toxicological detection of the new designer drug 3’,4’-methylenedioxy-alpha-pyrrolidinopropiophenone studied in urine using gas chromatography-mass spectrometry. J Chromatogr B: Anal Technol Biomed Life Sci 793:377–388.
   PubMed Web of Science ®Google Scholar
• Springer D, Fritschi G, Maurer HH. (2003b). Metabolism of the new designer drug alpha-pyrrolidinopropiophenone (PPP) and the toxicological detection of PPP and 4’-methyl-alpha-pyrrolidinopropiophenone (MPPP) studied in rat urine using gas chromatography-mass spectrometry. J Chromatogr B: Anal Technol Biomed Life Sci 796:253–266.
   PubMed Web of Science ®Google Scholar
• Springer D, Peters FT, Fritschi G, Maurer HH. (2002). Studies on the metabolism and toxicological detection of the new designer drug 4’-methyl-alpha-pyrrolidinopropiophenone in urine using gas chromatography-mass spectrometry. J Chromatogr B: Anal Technol Biomed Life Sci 773:25–33.
   PubMed Web of Science ®Google Scholar
• Springer D, Peters FT, Fritschi G, Maurer HH. (2003c). New designer drug 4’-methyl-alpha-pyrrolidinohexanophenone: studies on its metabolism and toxicological detection in urine using gas chromatography-mass spectrometry. J Chromatogr B: Anal Technol Biomed Life Sci 789:79–91.
   PubMed Web of Science ®Google Scholar
• Springer D, Peters FT, Fritschi G, Maurer HH. (2003d). New designer drug 4’-methyl-alpha-pyrrolidinohexanophenone: studies on its metabolism and toxicological detection in urine using gas chromatography–mass spectrometry. J Chromatogr B: Anal Technol Biomed Life Sci 5:79–91.
   Web of Science ®Google Scholar
• Springer D, Staack RF, Paul LD, et al. (2003e). Identification of cytochrome P450 enzymes involved in the metabolism of 4’-methoxy-alpha-pyrrolidinopropiophenone (MOPPP), a designer drug, in human liver microsomes. Xenobiotica 33:989–998.
   PubMed Web of Science ®Google Scholar
• Springer D, Staack RF, Paul LD, et al. (2005). Identification of cytochrome P450 enzymes involved in the metabolism of 3’,4’-methylenedioxy-alpha-pyrrolidinopropiophenone (MDPPP), a designer drug, in human liver microsomes. Xenobiotica 35:227–237.
   PubMed Web of Science ®Google Scholar
• Stiles BM, Fish AF, Cook CA, Silva V. (2016). Bath salt-induced psychosis: nursing assessment, diagnosis, treatment, and outcomes. Perspect Psychiatr Care 52:68–78.
   PubMed Web of Science ®Google Scholar
• Stogner JM, Miller BL. (2013). Investigating the 'bath salt' panic: The rarity of synthetic cathinone use among students in the United States. Drug Alcohol Rev 32:545–549.
   PubMed Web of Science ®Google Scholar
• Strano-Rossi S, Cadwallader AB, De La Torre X, Botre F. (2010). Toxicological determination and in vitro metabolism of the designer drug methylenedioxypyrovalerone (MDPV) by gas chromatography/mass spectrometry and liquid chromatography/quadrupole time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 24:2706–2714.
   PubMed Web of Science ®Google Scholar
• Strano-Rossi S, Odoardi S, Fisichella M, et al. (2014). Screening for new psychoactive substances in hair by ultrahigh performance liquid chromatography–electrospray ionization tandem mass spectrometry. J Chromatogr a 1372c:145–156.
   PubMed Web of Science ®Google Scholar
• Swortwood MJ, Hearn WL, Decaprio AP. (2014). Cross-reactivity of designer drugs, including cathinone derivatives, in commercial enzyme-linked immunosorbent assays. Drug Test Anal 6:716–727.
   PubMed Web of Science ®Google Scholar
• Sykutera M, Bloch-Bogusławska E. (2015). A fatal case of 3,4-dimethylmethcathinone poisoning. Prob Forensic Sci 102:138–148.
   Google Scholar
• Sykutera M, Cychowska M, Bloch-Boguslawska E. (2015). A fatal case of pentedrone and α-pyrrolidinovalerophenone poisoning. J Anal Toxicol 39:324–329.
   PubMed Web of Science ®Google Scholar
• Tang MH, Ching CK, Lee CY, et al. (2014). Simultaneous detection of 93 conventional and emerging drugs of abuse and their metabolites in urine by UHPLC-MS/MS. J Chromatogr B: Anal Technol Biomed Life Sci 969:272–284.
   PubMed Web of Science ®Google Scholar
• Tekulve K, Alexander A, Tormoehlen L. (2014). Seizures associated with synthetic cathinone exposures in the pediatric population. Pediatr Neurol 51:67–70.
   PubMed Web of Science ®Google Scholar
• Thornton SL, Gerona RR, Tomaszewski CA. (2012a). Psychosis from a bath salt product containing flephedrone and MDPV with serum, urine, and product quantification. J Med Toxicol 8:310–313.
   PubMedGoogle Scholar
• Thornton SL, Lo J, Clark RF, et al. (2012b). Simultaneous detection of multiple designer drugs in serum, urine, and CSF in a patient with prolonged psychosis. Clin Toxicol (Phila) 50:1165–1168.
   PubMed Web of Science ®Google Scholar
• Torrance H, Cooper G. (2010). The detection of mephedrone (4-methylmethcathinone) in 4 fatalities in Scotland. Forensic Sci Int 202:e62–e63.
   PubMed Web of Science ®Google Scholar
• Tsujikawa K, Kuwayama K, Kanamori T, et al. (2013). Thermal degradation of alpha-pyrrolidinopentiophenone during injection in gas chromatography/mass spectrometry. Forensic Sci Int 231:296–299.
   PubMed Web of Science ®Google Scholar
• Tsujikawa K, Mikuma T, Kuwayama K, et al. (2012). Degradation pathways of 4-methylmethcathinone in alkaline solution and stability of methcathinone analogs in various pH solutions. Forensic Sci Int 220:103–110.
   PubMed Web of Science ®Google Scholar
• Tyrkko E, Pelander A, Ketola RA, Ojanpera I. (2013). In silico and in vitro metabolism studies support identification of designer drugs in human urine by liquid chromatography/quadrupole-time-of-flight mass spectrometry. Anal Bioanal Chem 405:6697–6709.
   PubMed Web of Science ®Google Scholar
• United Nations Office on Drugs and Crime (UNODC). (2013). World Drug Report 2013. United Nations publication, Vienna, Sales No. E.13.X1.6.
   Google Scholar
• United Nations Office on Drugs and Crime (UNODC). (2015). World Drug Report 2015. United Nations Publication, Sales No. E.15.X1.6.
   Google Scholar
• Uralets V, Rana S, Morgan S, Ross W. (2014). Testing for designer stimulants: metabolic profiles of 16 synthetic cathinones excreted free in human urine. J Anal Toxicol 38:233–241.
   PubMed Web of Science ®Google Scholar
• US Drug Enforcement Administration. (2013a). Establishment of drug codes for 26 substances. Final rule. Fed Regist 78:664–666.
   PubMedGoogle Scholar
• US Drug Enforcement Administration. (2013b). Schedules of controlled substances: Placement of methylone into schedule I. Fed Regist 78:21818–21825.
   Google Scholar
• US Drug Enforcement Administration. (2014a). Schedules of controlled substances: Temporary placement of 10 synthetic cathinones into schedule I. Fed Regist 79:12938–12943.
   PubMedGoogle Scholar
• US Drug Enforcement Administration. (2014b). Special report: Synthetic cannabinoids and synthetic cathinones reported in NFLIS, 2010–2013. Springfield, VA.
   Google Scholar
• US Drug Enforcement Administration. (2015a). National Forensic Laboratory Information System (NFLIS): 2014 annual report. Springfield, VA.
   Google Scholar
• US Drug Enforcement Administration. (2015b). National Forensic Laboratory Information System (NFLIS): 2014 midyear report. Springfield, VA.
   Google Scholar
• US Drug Enforcement Administration. (2016). Schedules of Controlled Substances: Extension of Temporary Placement of 10 Synthetic Cathinones in Schedule I of the Controlled Substances Act. Fed Regist 81:11429–11431.
   PubMedGoogle Scholar
• Usui K, Aramaki T, Hashiyada M, et al. (2014). Quantitative analysis of 3,4-dimethylmethcathinone in blood and urine by liquid chromatography–tandem mass spectrometry in a fatal case. Leg Med (Tokyo) 16:222–226.
   PubMed Web of Science ®Google Scholar
• Vardakou I, Pistos C, Spiliopoulou C. (2011). Drugs for youth via Internet and the example of mephedrone. Toxicol Lett 201:191–195.
   PubMed Web of Science ®Google Scholar
• Wagner KD, Armenta RF, Roth AM, et al. (2014). Use of synthetic cathinones and cannabimimetics among injection drug users in San Diego, California. Drug Alcohol Depend 141:99–106.
   PubMed Web of Science ®Google Scholar
• Wikstrom M, Thelander G, Nystrom I, Kronstrand R. (2010). Two fatal intoxications with the new designer drug methedrone (4-methoxymethcathinone). J Anal Toxicol 34:594–598.
   PubMed Web of Science ®Google Scholar
• Winstock AR, Mitcheson LR, Deluca P, et al. (2011). Mephedrone, new kid for the chop? Addiction 106:154–161.
   PubMed Web of Science ®Google Scholar
• Wood DM, Davies S, Puchnarewicz M, et al. (2010). Recreational use of mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity. J Med Toxicol 6:327–330.
   PubMedGoogle Scholar
• Wright TH, Cline-Parhamovich K, Lajoie D, et al. (2013). Deaths involving methylenedioxypyrovalerone (MDPV) in Upper East Tennessee. J Forensic Sci 58:1558–1562.
   PubMed Web of Science ®Google Scholar
• Wyman JF, Lavins ES, Engelhart D, et al. (2013). Postmortem tissue distribution of MDPV following lethal intoxication by ‘bath salts‘. J Anal Toxicol 37:182–185.
   PubMed Web of Science ®Google Scholar
• Zaitsu K, Katagi M, Kamata HT, et al. (2009). Determination of the metabolites of the new designer drugs bk-MBDB and bk-MDEA in human urine. Forensic Sci Int 188:131–139.
   PubMed Web of Science ®Google Scholar
• Zaitsu K, Tatsuno M, Sato T, et al. (2011). Recently abused β-keto derivatives of 3,4-methylenedioxyphenylalkylamines: A review of their metabolisms and toxicological analysis. Forensic Toxicol 29:73–84.
   Web of Science ®Google Scholar
• Zawilska JB, Wojcieszak J. (2013). Designer cathinones-an emerging class of novel recreational drugs. Forensic Sci Int 231:42–53.
   PubMed Web of Science ®Google Scholar